John Burt, chief executive of Abzena plc (AIM:ABZA), tells Proactive's Andrew Scott the group expects turnover for the 12 months to the end of March to be in the order of ?22mln, up 18% on the year before, with underlying earnings (EBITDA) in line with expectations.
There was a marked split between halves, with sales up 49% in the second six months compared with the first.
Abzena's targeting top-line growth in 2019 at a "slightly higher rate" than 2018, with the performance expected to be second-half weighted.
Meet 360 Blockchain Inc, Alterola Biotech, Inc, LGC Capital Ltd and Blowfish Technology at our event,New York, 18 April 2018.Register here >>